CareRx

Canadian Healthcare Cost Cuts Will Crush Margins In Future

AnalystLowTarget

Not Invested

Community Contributor

Published

14 Aug 25

AnalystLowTarget's Fair Value

CA$2.25

58.2% overvalued

04 Sep

CA$3.56

64.8%

-0.6%

64.8%

-0.6%

You can edit this narrative until Aug 14 10:18 PM. Then, changes will post as Updates.

Author's Valuation

CA$2.2558.2% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

CA$2.25

58.2% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

5.52%

Food and Staples Retail revenue growth rate

0.18%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.47%

Calculation

CA$655.08k

Earnings '28

303.29x

PE Ratio '28

CA$198.68m

Market Cap '28

CA$198.68m

Market Cap '28

73.39m

No. shares '28

CA$2.71

Share Price '28

CA$2.71 Share Price '28

Discounted to 2025 @ 6.55% p.a.

CA$2.24

Fair Value '25